In vitro adenoviral vector p53-mediated transduction and killing correlates with expression of coxsackie-adenovirus receptor and α(v)β5 integrin in SUDHL-1 cells derived from anaplastic large-cell lymphoma

Clinical Cancer Research

Volumn 6, Issue 1, 2000, Pages 185-192

  Turturro, Francesco ^a,b,c   Seth, Prem ^a   Link Jr , Charles J ^a  

^a IOWA METHODIST MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Iowa Cancer Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; PROTEIN P53; VIRUS VECTOR;

ANAPLASTIC CARCINOMA; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA CONTENT; GENE THERAPY; HUMAN; HUMAN CELL; IN VITRO STUDY; LARGE CELL LYMPHOMA; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRIDAE; CELL CYCLE; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FLOW CYTOMETRY; GENES, P53; GENETIC VECTORS; HUMANS; IN SITU NICK-END LABELING; INTEGRINS; LYMPHOMA, LARGE-CELL; RECEPTORS, VIRUS; RECEPTORS, VITRONECTIN; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033968337     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Fraser, A., and Evan, G. A license to kill. Cell, 85: 781-784, 1996.
2. Hainaut, P. The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival. Curr. Opin. Oncol., 7: 76-82, 1995.
3. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992.
4. Liu, T. J., Zhang, W. W., Taylor, D. L., Roth, J. A., Goepfert, H., and Clayman, G. L. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res., 54: 3662-3667, 1994.
5. Katayose, D., Gudas, J., Nguyen, H., Srivastava, S., Cowan, K. H., and Seth, P. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells. Clin. Cancer Res., 1: 889-897, 1995.
6. Seth, P., Brinkman, U., Schwartz, G. N., Katayose, D., Gress, R., Pastan, I., and Cowan, K. Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging. Cancer Res., 56: 1346-1351, 1996.
7. Hamada, K., Alemany, R., Zhang, W. W., Hittleman, W. N., Lotan, R., Roth, J. A., and Mitchell, M. F. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer. Cancer Res., 56: 3047-3054, 1996.
8. Gallardo, D., Drazan, K. E., and McBride, W. H. Adenovirus based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity. Cancer Res., 56: 4891-4893, 1996.
9. Asgari, K., Sesterhenn, I. A., McLeod, D. G., Cowan, K., Moul, J. W., Seth, P., and Srivastava, S. Inhibition of the growth of preestablished subcutaneous tumor nodules of human prostate cancer cells by single injection of the recombinant adenovirus p53 expression vector. Int. J. Cancer, 71: 377-382, 1997.
10. Li, Z., Rakkar, A., Katayose, Y., Kim, M., Shanmugam, N., Srivastava, S., Moul, J. W., McLeod, D. G., Cowan, K. H., and Seth, P. Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model. Gene Ther., 5: 605-613, 1998.
11. Nielsen, L. L., and Maneval, D. C. p53 tumor suppressor gene therapy for cancer. Cancer Gene Ther., 5: 52-63, 1998.
12. Huang, S., Endo, R. I., and Nemerov, G. R. Up-regulation of integrins αvnβ3 and αvnβ5 on human monocytes and T lymphocytes facilitates adenovirus mediated gene delivery. J. Virol., 69: 2257-2263, 1995.
13. Tomko, R. P., Xu, R., and Philipson, L. H-CAR, and M-CAR: the human and mouse cellular receptors for subgroup C adenovirus and group B coxsackieviruses. Proc. Natl. Acad. Sci. USA, 94: 3352-3356, 1997.
14. Bergelson, J. M., Cunningham, J. A., Drognett, G., Kurt-Jones, A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., and Finberg, R. W. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science (Washington DC), 275: 1320-1323, 1997.
15. Turturro, F., Lay, L. T., Wroblesky, J. M., Seth, P., and Meeker, T. C. Adenoviral vectors efficiently target cell lines derived from selected lymphocytic malignancies. Blood, 88: 294b, 1996.
16. Meeker, T. C., Lay, L. T., Wroblewsky, J. M., Turturro, F., Li, Z., and Seth, P. Adenoviral vectors efficiently target cell lines derived from selected lymphocytic malignancies including anaplastic large cell lymphoma and Hodgkin's Disease. Clin. Cancer Res., 3: 357-364, 1997.
17. Morgan, R., Smith, S. D., Hecht, B. K., Christy, V., Mellentin, J. D., Warnke, R., and Cleary, M. L. Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so called malignant hystiocytosis. Blood, 73: 2155-2164, 1989.
18. Kastan, M. B., Oneykwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
19. Hsu, K. H., Lonberg-Holm, K., Alstein, B., and Crowell, R. L. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J. Virol., 62: 1647-1652, 1988.
20. Freimuth, P. A human cell line selected for resistance to adenovirus infection has reduced levels of the virus receptor. J. Virol., 70: 4081-4085, 1996.
21. Cantwell, M. J., Sharma, S., Friedmann, T., and Kipps, T. J. Adenovirus vector infection of Chronic Lymphocytic Leukemia B cells. Blood, 88: 4676-4683, 1996.
22. Huang, M. R., Olsson, M., Kallin, A., Pettersson, U., and Totterman, T. H. Efficient adenovirus-mediated gene transduction of normal and leukemic hematopoietic cells. Gene Ther., 4: 1093-1099, 1997.
23. Stewart, A. K., Schimmer, A. D., Bailey, D. J., Dube, I. D., Cappe, D., Moen, R. C., Gauldie, J., and Graham, F. L. In vivo adenoviralmediated gene transfer of interleukin-2 in cutaneous plasmacytoma. Blood, 91: 1095-1097, 1998.
24. Prince, H. M., Dessureault, S., Gallinger, S., Krajden, M., Sutherland, D. R., Addison, C., Zhang, Y., Graham, F. L, and Stewart, A. K. Efficient adenovirus-mediated gene expression in malignant human plasma cells: relative lymphoid cell resistance. Exp. Hematol., 26: 27-36, 1998.
25. Teoh, G., Chen, L., Urashima, M., Tai, Y. T., Celi, L. A., Chen, D., Chauhan, D., Ogata, A., Finberg, R. W., Webb, I. J., Kufe, D. W., and Anderson, K. C. Adenovirus vector-based purging of multiple myeloma cells. Blood. 92: 4591-4601, 1998.
26. Wroblewsky, J. M., Lay, L. T., Van Zant, G., Phillips, G., Seth, P., Curiel, D., and Meeker, T. C. Selective elimination (purging) of contaminating malignant cells from hematopoietic stem cell autografts using recombinant adenovirus. Cancer Gene Ther., 3: 257-264, 1996.
27. Inghirami, G., Macri, L., Ceserman, E., Chadburn, A., Zhong, J., and Knowles. D. M. Molecular characterization of CD30+ anaplastic large cell lymphoma: high frequency of c-myc proto-oncogene activation. Blood, 12: 3581-3590, 1994.
28. Waldman, T., Kinzler, K. W., and Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res., 55: 5187-5190, 1995.
29. Agarwal, L. M., Agarwal, A., Taylor, W. R., and Stark, G. R. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA, 92: 8493-8497, 1995.
30. Gorczyca, W., Gong, J., and Darzynkiewicz, Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res., 53: 1945-1951, 1993.
31. Tilly, H., Gaulard, P., Lepage, E., Dumontet, C., Diebold, J., Plantier, I., Berger, F., Symann, M., Petrella, T., Lederlin, P., and Briere, J. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood, 90: 3727-3734, 1997.
32. Delsol, G., Al Saati, T., Gatter, K. C., Gerdes, J., Schwarting, G., Caveriviere, P., Rigal-Huguet, S., Robert, A., Stein, H., and Mason, D. Y. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Am. J. Pathol., 130: 59-70, 1988.
33. Gustmann, C., Altmannsberger, M., Osborn, M., Griesser, H., and Feller, A. C. Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other Non-Hodgkin's Lymphomas. Am. J. Pathol., 138: 1413-1422, 1991.
34. Stroeken, P. J. M., van Rijthoven, E. A. M., van der Valk, M. A., and Roos, E. Targeted disruption of the β1 integrin gene in a lymphoma cell line greatly reduces metastatic capacity. Cancer Res., 58: 1569-1577, 1998.
35. Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., and Look, A. T. Fusion of a kinase gene, ALK to a nuclear protein gene, NPM in non-Hodgkin's lymphoma. Science (Washington DC), 263: 1281-1284, 1994.
36. Mitev, L., Christova, S., Hadjiev, E., Guenova, M., Oucheva, R., Valkov, I., and Manolova, Y. A new variant chromosomal translocation t(2;2)(p23;q23) in CD30+/Kil+ anaplastic large cell lymphoma. Leuk. Lymphoma, 28: 613-616, 1998.
37. Falini, B., Bigerna, B., Fizzotti, M., Pulford, K., Pileri, S. A., Delsol, G., Carbone, A., Paulli, M., Magrini, U., Menestrina, F., Giardini, R., Pilotti, S., Mezzelani, A., Ugolini, B., Billi, M., Pucciarini, A., Pacini, R., Pellicci, P. G., and Flenghi, L. ALK expression defines a distinct group of T/Null lymphomas ("ALK lymphomas") with a wide morphological spectrum. Am. J. Pathol., 153: 875-886, 1998.
38. Frederick, M. J., Holton, P. R., Hudson, M., Wang, M., and Clayman, G. L. Expression of apoptosis related genes in human head and neck squamous cell carcinomas undergoing p53 mediated programmed cell death. Cancer Res., 5: 361-369, 1999.
39. Hemmi, S., Geertsen, R., Mezzacasa, A., Peter, I., and Dummer, R. The presence of human coxsackievirus and adenovirus-mediated transgene expression in human melanoma cell cultures. Hum. Gene Ther., 9: 2363-2373, 1998.
40. Turturro, F., Drevyanko, T. F., Heineke, H. L., and Link, C. J. Establishment of anaplastic large cell lymphoma (ALCL) model in athymic mice: in vivo adenoviral p53 gene therapy for lymphoma. Blood, 92: 382b, 1998.